Andrew D. Dickinson - 17 Feb 2026 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Signature
/s/ Edward S. Son by Power of Attorney for Andrew D. Dickinson
Issuer symbol
GILD
Transactions as of
17 Feb 2026
Net transactions value
-$463,290
Form type
4
Filing time
18 Feb 2026, 17:11:41 UTC
Previous filing
05 Feb 2026
Next filing
02 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dickinson Andrew D Chief Financial Officer GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY /s/ Edward S. Son by Power of Attorney for Andrew D. Dickinson 18 Feb 2026 0001310204

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Sale $463,290 -3,000 -1.8% $154.43 167,779 17 Feb 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.
F2 Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.